Date & Time of Session - 10/2/26 - from 12-1 PM
Location:Todd234 - Tuesdays & MN263 - Fridays

Overview
Factor XI inhibition offers a unique mechanism for anticoagulation by inhibiting the intrinsic pathway of the coagulation cascade while attenuating hemostasis via the extrinsic pathway. This mechanism provides a potential advantage over traditional anticoagulation by reducing clot risk while maintaining a low bleed risk. The clinical trial data is heavily mixed depending on the indication for use. Nonetheless, the first positive phase III trial involving a Factor XI inhibitor was published in early 2026. These reasons ultimately highlight the need to discuss these upcoming agents to prepare pharmacists for appropriate and safe utilizations as they approach market approval. 

Objectives
Upon completion of this activity, participants will be able to:
1. Review the background surrounding history of Factor XI inhibitors and their impact on the clotting cascade 
2. Evaluate the clinical trials available to date for proposed Factor XI inhibitor use for different indications 
3. Discuss clinical considerations regarding future use of Factor XI inhibitors 


Speaker
Theodore Blum, PharmD
PGY2 Cardiology Resident 
UK College of Pharmacy – Lexington, Kentucky

Target Audience: 
The audience includes pharmacy management, pharmacists, pharmacy residents, and pharmacy students. 

Special Services
If you require special assistance to attend this event, please call Jacob Brooks at (606) 304-7493 or [email protected].

An Equal Opportunity University
 

Session date: 
10/02/2026 - 12:00pm EDT to 11/30/2026 - 10:59pm EST
Location: 
UK College of Pharmacy
789 Vine Street
Lexington, KY 40536
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-26-073-L01-P

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Theodore Blum, PharmD

has no relevant financial relationships to disclose at this time.